-
Mashup Score: 1Real-World Perspectives in Managing CLL Treatment - 1 month(s) ago
Support for this activity has been provided through educational grants from AbbVie Inc. and AstraZeneca Pharmaceuticals. Estimated time to complete: 0.75 hours Management op tions for chronic lymphocytic leukemia (CLL) have expanded in recent years. The emergence of new immunotherapeutic and targeted agents for both the first-line and relapsed/refractory settings — though of course beneficial for CLL patients — represents a challenge to clinicians, who must navigate the indicated uses, mechanisms of
Source: education.redmeded.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Real-World Perspectives in Managing CLL Treatment - 3 month(s) ago
Support for this activity has been provided through educational grants from AbbVie Inc. and AstraZeneca Pharmaceuticals. Estimated time to complete: 0.75 hours Management op tions for chronic lymphocytic leukemia (CLL) have expanded in recent years. The emergence of new immunotherapeutic and targeted agents for both the first-line and relapsed/refractory settings — though of course beneficial for CLL patients — represents a challenge to clinicians, who must navigate the indicated uses, mechanisms of
Source: education.redmeded.comCategories: General Medicine News, Onc News and JournalsTweet-
RT @RedMedEd: Review the latest CLL treatments, molecular tests, management strategies—and more……https://t.co/53UTs1XINN with @LRoekerMDand…
-
-
Mashup Score: 1Myeloma Masters: The Ultimate Myeloma Patient Care Quiz Show - 2 year(s) ago
Jointly provided by Support for this activity has been provided through educational grants from Karyopharm Therapeutics, Inc. and Sanofi Genzyme.Release date: 4/27/2022Expiration date: 4/27/2023Estimated time to complete: 0.5 hourOverviewMultiple myeloma management has advanced significantly in recent years, providing new hope for myeloma patients but creating new challenges for health care…
Source: education.redmeded.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @RedMedEd: Are you a Myeloma Master? Play a round to find out and earn NCPD to boot! https://t.co/UIyVU3aHvI #mmsm @theMMRF https://t.co…
-
-
Mashup Score: 4
Jointly provided by Support for this activity has been provided through educational grants from Adaptive Biotechnologies Corporation; Amgen, Inc.; Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc.; and Oncopeptides.The joint sponsors also wish to thank CURE and Targeted Oncology for their support.Release…
Source: education.redmeded.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @RedMedEd: Consult our expert panel in a virtual Q&A on #myeloma patient care. @theMMRF #mmsm https://t.co/UepjxzAKzx https://t.co/YFODw…
-
RT @RedMedEd: Review the latest CLL treatments, molecular tests, management strategies—and more……https://t.co/53UTs1XINN with @LRoekerMDand…